Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

US Patent 10813942 · Granted Oct 27, 2020

Estimated economic value: $309,700,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors2023
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors2021
Tissue-specific genome engineering using CRISPR-Cas92020
Tissue-specific genome engineering using CRISPR-Cas92020
Tissue-specific genome engineering using CRISPR-Cas92020
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors2020
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents2019
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents2019
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents2019
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors2019
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents2018
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents2018